Skip to content

A study to compare two Ayurvedic medicines (Panchmooladi syrup and Shati compound syrup) in the management of Vataja Kasa among children aged 3 to 10 years.

A randomized comparative clinical study to evaluate the efficacy of Panchmooladi Syrup and Shati Compound in the management of Vataja Kasa among children aged 3 to 10 years. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104024
Enrollment
64
Registered
2026-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J06- Acute upper respiratory infections

Interventions

None listed

Sponsors

PDEAs College of Ayurved and Research Centre Nigdi, Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects having any two or more classical signs and symptoms of Vataja Kasa, including shushka Kasa described in the context of Vataja Kasa, such as Shushka Kasa, Shirashoola, Swarabheda, Parshwashoola, Uroshoola, Shushka mukha, and gala. 2) Subjects between the age group of 3 to 10 years irrespective of gender, religion, or socioeconomic status will be taken. 3) Subjects having Kasa with symptoms for less than 7 days duration.

Exclusion criteria

Exclusion criteria: 1) Kasa as Anubandha Lakshan in other systemic diseases. 2) Patients presenting with symptoms of Tamaka Shwasa (bronchial asthma). 3) Kasa associated with Jwara. 4) Known case of pneumonia, emphysema, diphtheria, pertussis, obstructive bronchitis, bronchiectasis, lung abscess, and pulmonary edema resulting from cardiac and renal diseases. 5) Known case of Kochs, HIV, and other debilitating diseases. 6) Known case of congenital anomalies of the respiratory system.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Panchmooladi syrup and Shati compound in the management of Vataj Kasa in children aged 3 to 10 years over 7 daysTimepoint: 7 Days, where Follow up will be on the 3rd, 5th, and 7th day.

Secondary

MeasureTime frame
To observe the adverse effects if anyTimepoint: 7 Days, where Follow up will be on the 3rd, 5th, and 7th day.

Countries

India

Contacts

Public ContactDr Deepa Khasgiwala

PDEAs College of Ayurved and Research Centre, Nigdi, Pune

drdeepajain@yahoo.co.in9890077765

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026